These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 15608059)

  • 1. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum.
    Valjent E; Pascoli V; Svenningsson P; Paul S; Enslen H; Corvol JC; Stipanovich A; Caboche J; Lombroso PJ; Nairn AC; Greengard P; Hervé D; Girault JA
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):491-6. PubMed ID: 15608059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.
    Nishi A; Watanabe Y; Higashi H; Tanaka M; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1199-204. PubMed ID: 15657149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
    J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
    Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
    Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-regulated protein kinases 1 and 2 activation by addictive drugs: a signal toward pathological adaptation.
    Pascoli V; Cahill E; Bellivier F; Caboche J; Vanhoutte P
    Biol Psychiatry; 2014 Dec; 76(12):917-26. PubMed ID: 24844603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DARPP-32: A molecular switch at the nexus of reward pathway plasticity.
    Gould TD; Manji HK
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):253-4. PubMed ID: 15632217
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol.
    Valjent E; Bertran-Gonzalez J; Aubier B; Greengard P; Hervé D; Girault JA
    Neuropsychopharmacology; 2010 Jan; 35(2):401-15. PubMed ID: 19759531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.
    Snyder GL; Fienberg AA; Huganir RL; Greengard P
    J Neurosci; 1998 Dec; 18(24):10297-303. PubMed ID: 9852567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol.
    Bertran-Gonzalez J; Bosch C; Maroteaux M; Matamales M; Hervé D; Valjent E; Girault JA
    J Neurosci; 2008 May; 28(22):5671-85. PubMed ID: 18509028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
    Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
    J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A; Usiello A; Greengard P; Fisone G
    Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
    Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
    Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties.
    Valjent E; Corvol JC; Pages C; Besson MJ; Maldonado R; Caboche J
    J Neurosci; 2000 Dec; 20(23):8701-9. PubMed ID: 11102476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the ERK pathway in psychostimulant-induced locomotor sensitization.
    Valjent E; Corvol JC; Trzaskos JM; Girault JA; Hervé D
    BMC Neurosci; 2006 Mar; 7():20. PubMed ID: 16512905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
    Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase.
    Gerfen CR; Paletzki R; Worley P
    J Neurosci; 2008 Jul; 28(28):7113-20. PubMed ID: 18614680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
    Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
    Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.
    Halpain S; Girault JA; Greengard P
    Nature; 1990 Jan; 343(6256):369-72. PubMed ID: 2153935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.
    Corbillé AG; Valjent E; Marsicano G; Ledent C; Lutz B; Hervé D; Girault JA
    J Neurosci; 2007 Jun; 27(26):6937-47. PubMed ID: 17596442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.
    Fienberg AA; Hiroi N; Mermelstein PG; Song W; Snyder GL; Nishi A; Cheramy A; O'Callaghan JP; Miller DB; Cole DG; Corbett R; Haile CN; Cooper DC; Onn SP; Grace AA; Ouimet CC; White FJ; Hyman SE; Surmeier DJ; Girault J; Nestler EJ; Greengard P
    Science; 1998 Aug; 281(5378):838-42. PubMed ID: 9694658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.